IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Ann Neurol. 1998 Aug;44(2):202-8. doi: 10.1002/ana.410440210.
Ann Neurol. 1998.
PMID: 9708542
Clinical Trial.